Emergent BioSolutions Wins $56 Million Order for Vaccine Supply to US Government

MT Newswires Live

09/09

Emergent BioSolutions (EBS) said Tuesday it has won a $56 million additional order from the US government to supply ACAM2000, a vaccine for smallpox and Mpox.

The company said that this additional order is being executed through a contract modification and the deliveries are expected to begin this month.

It added that with this modification, the total projected sales for its vaccine and ancillary products is expected to be more than $120 million this year from a diverse base of customers.

Emergent BioSolutions said that this contract modification is under its existing 10-year contract with the Administration for Strategic Preparedness and Response at the United States Department of Health and Human Services.

Emergent BioSolutions shares were up close to 2% in recent premarket activity.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2566692548"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2566692548\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2566692548?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-09-09 20:10","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2566692548","market":"sh","top_or_hot":-1,"title":"Emergent BioSolutions Wins $56 Million Order for Vaccine Supply to US Government","media":"MT Newswires Live","content":"<html><body><p> Emergent BioSolutions (EBS) said Tuesday it has won a $56 million additional order from the US government to supply ACAM2000, a vaccine for smallpox and Mpox.</p><p>The company said that this additional order is being executed through a contract modification and the deliveries are expected to begin this month.</p><p>It added that with this modification, the total projected sales for its vaccine and ancillary products is expected to be more than $120 million this year from a diverse base of customers.</p><p>Emergent BioSolutions said that this contract modification is under its existing 10-year contract with the Administration for Strategic Preparedness and Response at the United States Department of Health and Human Services.</p><p>Emergent BioSolutions shares were up close to 2% in recent premarket activity.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Emergent BioSolutions Wins $56 Million Order for Vaccine Supply to US Government</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEmergent BioSolutions Wins $56 Million Order for Vaccine Supply to US Government\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time smaller\">2025-09-09 20:10</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html><body><p> Emergent BioSolutions (EBS) said Tuesday it has won a $56 million additional order from the US government to supply ACAM2000, a vaccine for smallpox and Mpox.</p><p>The company said that this additional order is being executed through a contract modification and the deliveries are expected to begin this month.</p><p>It added that with this modification, the total projected sales for its vaccine and ancillary products is expected to be more than $120 million this year from a diverse base of customers.</p><p>Emergent BioSolutions said that this contract modification is under its existing 10-year contract with the Administration for Strategic Preparedness and Response at the United States Department of Health and Human Services.</p><p>Emergent BioSolutions shares were up close to 2% in recent premarket activity.</p></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4583","symbol_name":"猴痘概念","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2566692548","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2566692548","pubTimestamp":1757419855,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Emergent BioSolutions  said Tuesday it has won a $56 million additional order from the US government to supply ACAM2000, a vaccine for smallpox and Mpox.The company said that this additional order is being executed through a contract modification and the deliveries are expected to begin this month.It added that with this modification, the total projected sales for its vaccine and ancillary products is expected to be more than $120 million this year from a diverse base of customers.Emergent BioSolutions said that this contract modification is under its existing 10-year contract with the Administration for Strategic Preparedness and Response at the United States Department of Health and Human Services.Emergent BioSolutions shares were up close to 2% in recent premarket activity.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4583":"猴痘概念","EBS":"Emergent Biosolutions","BK4139":"生物科技"},"translate_title":"Emergent BioSolutions赢得美国政府5600万美元疫苗供应订单","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"EBS":1},"content_text":"Emergent BioSolutions (EBS) said Tuesday it has won a $56 million additional order from the US government to supply ACAM2000, a vaccine for smallpox and Mpox.The company said that this additional order is being executed through a contract modification and the deliveries are expected to begin this month.It added that with this modification, the total projected sales for its vaccine and ancillary products is expected to be more than $120 million this year from a diverse base of customers.Emergent BioSolutions said that this contract modification is under its existing 10-year contract with the Administration for Strategic Preparedness and Response at the United States Department of Health and Human Services.Emergent BioSolutions shares were up close to 2% in recent premarket activity.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"corporation,merge","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}